Lecture 3

Lecture Overview

• Topic: Research in Medicine and Healthcare (Part 1)

• Themes:

  • Experimental models in health research: Explores various models from cellular to animal systems used to understand disease mechanisms and test interventions.

  • Evidence-based medicine: Focuses on integrating the best research evidence with clinical expertise and patient values in healthcare decision-making.

  • New dimensions in healthcare, including AI: Discusses emerging technologies and methodologies transforming research and clinical practice, such as artificial intelligence and large-scale data analysis.

Evidence-Based Medicine

• Definition: A systematic approach to clinical decision-making that integrates the best available research evidence, clinical expertise, and patient preferences and values.

• Hierarchy of Evidence Pyramid:

  • A visual representation illustrating the strength of different study designs, with randomized controlled trials (RCTs) and systematic reviews/meta-analyses typically at the top, offering the strongest evidence.

  • Shows levels of evidence from low to high; higher is better for making clinical decisions as it minimizes bias and confounding factors.

• Low Evidence Levels:

  • Animal Models (e.g., rodent studies) - Example: Mice on a high-fat diet and cardiovascular outcomes provide initial insights but require validation in humans.

  • In Vitro (test tube/cell culture) and In Silico (computer simulation) research are also considered lower-level evidence when directly applied to human health without further validation.

• Importance of Progressing the Evidence:

  • Low-level evidence (animal studies, in vitro) is crucial for hypothesis generation and mechanistic understanding but should not directly inform human clinical decisions without validation through higher-level human studies.

  • This progression is essential to ensure safety, efficacy, and generalizability of findings to the human population.

• Higher Levels of Evidence:

  • Original studies like randomized control trials (RCTs) are considered the gold standard for establishing cause and effect relationships due to their ability to minimize bias through randomization and control groups.

  • Systematic reviews and meta-analyses, which synthesize multiple RCTs, provide the highest level of evidence.

Research Types

• Original Research vs. Review

  • Original: Primary studies that collect and analyze new data (e.g., clinical trials, observational studies, basic laboratory experiments). At the core of generating new scientific knowledge.

  • Review: Secondary studies that analyze and synthesize existing literature to derive new conclusions, identify gaps, or summarize current knowledge (e.g., narrative reviews, systematic reviews, meta-analyses).

• RCTs (Randomized Controlled Trials): Considered the most robust experimental design for intervention studies; they allow for the conclusion of cause and effect by randomly assigning participants to intervention or control groups, minimizing confounding.

• In Silico Research:

  • Involves computer simulations, mathematical modeling, and bioinformatics to analyze large datasets and predict outcomes.

  • Example: GWAS (Genome-Wide Association Study) uses computational tools to identify genetic variants associated with specific diseases or traits by analyzing millions of genetic markers across many individuals.

  • Facilitates drug discovery by simulating molecular interactions and predicting efficacy/toxicity.

• In Vitro (in glass, e.g., petri dish) and Ex Vivo (out of living organism) Research:

  • In Vitro: Studies conducted with biological components isolated from their natural environment, such as cell cultures, tissue samples, or biomolecules (e.g., studying drug effects on cancer cells in a petri dish).

  • Ex Vivo: Studies performed on tissues or organs removed from a living organism and maintained in an artificial environment (e.g., studying drug metabolism in an isolated perfused liver).

Significance of Different Experimental Models

• These diverse models (in silico, in vitro, ex vivo, animal) allow for the investigation of fundamental biological mechanisms, disease pathophysiology, and initial testing of potential therapeutic agents or interventions before human clinical trials.

• They serve as crucial stepping stones to human research, providing foundational data and hypothesis generation.

• Controlled Conditions: It is significantly easier to manage and manipulate variables, genetic backgrounds, and environmental factors in animal studies and in vitro models compared to complex human clinical trials, allowing for clearer cause-and-effect investigations.

Animal Models in Health Research

• Typically focus on rodents (e.g., mice and rats) due to their relatively short lifespans, ease of breeding, genetic tractability (ability to manipulate genes), and significant physiological and genetic similarities to humans for many biological processes.

• Examples:

  • Zucker Rat: A widely used genetic model for studying obesity, type 2 diabetes, and metabolic syndrome due to a mutation in the leptin receptor.

  • OBOB Mouse: A genetic model with a mutation in the leptin gene, leading to severe obesity and diabetes; useful for studying leptin's role but considered an extreme model due to the total lack of functional leptin, which is rare in human obesity.

  • Other models include nematodes (C. elegans) and fruit flies (Drosophila melanogaster) for more minor research tasks, particularly in genetics, developmental biology, and studies of aging due to their simpler systems and rapid reproduction.

Ethical Implications in Using Animal Models

• A continuous tension exists between the scientific advantages of using animals (e.g., genetic similarity to humans, ability to control environments) and the ethical concerns regarding their welfare, pain, and suffering.

• Research involving animals is highly regulated, often guided by the "3Rs" principles: Replacement (using non-animal methods wherever possible), Reduction (minimizing the number of animals used), and Refinement (improving animal welfare and minimizing pain/distress).

Human Studies

• Nonclinical (Observational) Studies:

  • Studies that observe phenomena without researcher intervention (e.g., dietary surveys, epidemiological studies observing disease patterns, cohort studies following groups over time, case-control studies comparing exposures in diseased vs. non-diseased individuals).

  • Limitations: Only associations can be drawn; these studies cannot definitively establish causation due to potential confounding variables.

  • Strengths: Can generate hypotheses, identify risk factors, and study rare diseases or long-term outcomes in real-world settings.

• Clinical (Interventional) Studies:

  • Designed to test specific treatments or interventions by actively administering them to participants (e.g., clinical trials for new drugs, surgical procedures, or behavioral therapies).

  • Double-blind RCTs (where neither participants nor researchers know who is receiving the intervention vs. placebo) are the strongest evidence for treatment efficacy, minimizing both participant and investigator bias.

  • Provides the most reliable evidence for cause-effect relationships in human populations, crucial for informing clinical practice.

Key Takeaways

• Understanding the different models and hierarchy of evidence is crucial for competently interpreting research results, critically evaluating scientific claims, and applying findings to clinical practice safely and effectively.

• Nonclinical (observational) studies help generate hypotheses and identify potential relationships that can later be rigorously tested through more controlled clinical research.

• Clinical intervention studies, particularly well-designed randomized controlled trials, represent the top of the evidence hierarchy, providing the most reliable and unbiased data for making informed treatment decisions and improving patient care.